DT&CRO CO., Ltd. (KOSDAQ:383930)
3,360.00
+105.00 (3.23%)
At close: Apr 2, 2026
DT&CRO CO. Market Cap
DT&CRO CO. has a market cap or net worth of 42.89 billion as of April 2, 2026. Its market cap has decreased by -51.18% in one year.
Market Cap
42.89B
Enterprise Value
78.41B
Revenue
47.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,360.00
Market Cap Chart
Since November 11, 2022, DT&CRO CO.'s market cap has decreased from 87.47B to 42.89B, a decrease of -50.96%. That is a compound annual growth rate of -18.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 42.95B | 29.73% |
| Dec 30, 2025 | 33.11B | -55.30% |
| Dec 30, 2024 | 74.07B | -67.91% |
| Dec 28, 2023 | 230.80B | 305.63% |
| Dec 29, 2022 | 56.90B | -34.95% |
| Nov 11, 2022 | 87.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 605.13B |
| DreamCIS | 122.89B |
| HLB bioStep | 103.81B |
| P&K Skin Research Center | 59.79B |
| C&R Research | 46.09B |
| WOOJUNG BIO | 45.52B |
| SLS BIO | 26.89B |
| BioInfra | 19.31B |